Cancer Cells Degrade the Nanoparticle Protein Corona for Biosynthesis
Journal of the American Chemical Society · 2026-03-11 · 148 (9) · 9478-9493
DOI: 10.1021/jacs.5c19355 ↗At a glance
Journal article in Journal of the American Chemical Society, published online on 2026-02-25. Written by Qin Ji and 5 co-authors. Institution: Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, Toronto, Ontario M5S 3G9, Canada. Major MEDLINE topics: Gold, Protein Corona, Metal Nanoparticles, Nanoparticles. Cited 6 times so far (Crossref); 51 references. Funded by: University of Toronto, Canada Research Chairs, Natural Sciences and Engineering Research Council of Canada (NSERC).
Abstract (original language)
Nanoparticles designed to carry medical agents are administered to patients for the detection and treatment of cancer. Serum proteins form a protein corona on the nanoparticle surface after nanoparticles enter the bloodstream. The protein corona can impact how nanoparticles circulate, interact with, and get taken up by cancer cells. What happens to the protein corona once inside the cells remains unclear. Here, we discovered that cancer cells metabolize the protein corona to synthesize new macromolecules. After internalization, nanoparticles and their associated protein corona are trafficked to cell lysosomes. Proteolytic enzymes degrade the protein corona into amino acids in the lysosomes. The degraded byproducts are utilized for the synthesis of macromolecules for new cells. The total amount of serum proteins entering cells with the nanoparticles is greater than that in solution. Each internalized 55 nm gold nanoparticle transports an amount of protein equivalent to the uptake of over 250 individual proteins from solution. The uptake of nanoparticles creates an abundance of proteins for cells to carry out biosynthesis. These findings reveal that the nanoparticle protein corona serves as a nutrient reservoir for cancer cell metabolism.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, Toronto, Ontario M5S 3G9, Canada.
- Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
- Innovative Genomics Institute, University of California Berkeley, Berkeley, California 94720, United States.
- Gladstone Institute of Data Science and Biotechnology, San Francisco, California 94158, United States.
- Institute for Quantitative Biosciences, Berkeley, California 94720-3220, United States.
ORCID profiles: Colin Blackadar, Shrey Sindhwani, Warren C W Chan
Funding
- University of Toronto
- Canada Research Chairs
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Canadian Institutes of Health Research (CIHR)
Cite
APA
Ji, Q., Blackadar, C., Chang, A. C. Y., Wu, J. L. Y., Sindhwani, S., & Chan, W. C. W. (2026). Cancer Cells Degrade the Nanoparticle Protein Corona for Biosynthesis. Journal of the American Chemical Society, 148(9), 9478-9493. https://doi.org/10.1021/jacs.5c19355
Vancouver
Ji Q, Blackadar C, Chang ACY, Wu JLY, Sindhwani S, Chan WCW. Cancer Cells Degrade the Nanoparticle Protein Corona for Biosynthesis. Journal of the American Chemical Society. 2026;148(9):9478-9493. doi:10.1021/jacs.5c19355
BibTeX
@article{Ji2026,
author = {Ji, Qin and Blackadar, Colin and Chang, Atta C Y and Wu, Jamie L Y and Sindhwani, Shrey and Chan, Warren C W},
title = {Cancer Cells Degrade the Nanoparticle Protein Corona for Biosynthesis},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {9},
pages = {9478--9493},
doi = {10.1021/jacs.5c19355}
}
EUVIMED